An investigation of NSCLC cells reported a novel PPAR ligand candidate, PPZ023 (1-(2-(ethylthio) benzyl)-4-(2-methoxyphenyl) piperazine), that decreases cell viability while increasing LDH cytotoxicity and caspase-3 activity. Here, PPARA is linked to non-small cell lung carcinoma.